(Reuters) – The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.
Read more at the source: Nestle raises stake in food allergy drug developer Aimmune
